Sarm AC-262

AC-262, also known as AC-262536, is a selective androgen receptor modulator (SARM) developed primarily for research into conditions related to muscle wasting, osteoporosis, and other degenerative muscle disorders. It’s part of a class of compounds designed to provide the anabolic (muscle-building) benefits of traditional anabolic steroids, but with more tissue specificity and fewer androgenic (masculinizing) side effects. Sarms are research chemicals and not intended for human consumption.

Mechanism of Action:
AC-262 binds selectively to androgen receptors in muscle and bone tissues. Once bound, it stimulates protein synthesis and promotes muscle growth, similar to testosterone, but with reduced impact on organs like the prostate. Its selective nature aims to minimize the unwanted androgenic effects commonly associated with steroid use, such as hair loss, acne, or prostate enlargement.

Potential Benefits:

Muscle growth and improved lean body mass.
Potential support for bone density and strength, making it of interest in osteoporosis research.
Possible aid in recovery from muscle-wasting conditions, such as sarcopenia or cachexia.

Pharmacokinetics:
Research on AC-262 is limited compared to more well-known SARMs like Ostarine (MK-2866). Animal studies suggest good oral bioavailability and the ability to achieve anabolic effects at relatively low doses. Human data is very scarce, so precise dosing, half-life, and metabolism are not well-established.

Side Effects and Risks:
Because human research is minimal, safety data is largely unknown. Animal studies indicate a lower risk of liver toxicity and androgenic side effects compared to traditional anabolic steroids, but long-term effects are uncertain. Potential risks may include hormonal suppression, cholesterol changes, or unknown cardiovascular effects.

Forms and Administration:
AC-262 is typically used as an oral compound in research settings. It’s rarely found in legitimate clinical trials and is mainly restricted to experimental use. There are no approved medical formulations for humans.

Legal Status:
AC-262 is not FDA-approved for medical use. It is classified as a research chemical and is often marketed in the supplement or experimental research space. Sale for human consumption is generally illegal in many countries.

AC-262536 (AC-262) has extremely limited human research, so there is no officially established safe or effective dose for humans. Most of the information available comes from animal studies, and extrapolating to humans carries significant uncertainty. Any “dosing” circulating online is speculative and based on anecdotal reports from the research chemical community.